4
Changes in Ownership
CRESCENT BIOPHARMA, INC. Filed Acc 0001628280-26-062700
President and COO sold 4,570 shares at an average $16.90 ($77,235)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
McNeill Jonathan · President and COO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-16 | Sale : show line 1 in the form 10b5-1 | −731 | $17.90 | $13,085 | 138,427 | D |
| 2026-09-18 | Sale : show line 2 in the form 10b5-1 | −3,839 | $16.71 | $64,150 | 134,588 | D |
| Open-market sales · 4,570 sh · avg $16.90 · $77,235 | ||||||
Loading xslF345X06/wk-form4_1789761701.xml…